Patients Share Of Expensive Specialty Drugs Is Rising - Kaiser Health News
"....The coinsurance was killing them. "It was a choice between that and eating," says Gary Ryness.
Working with an insurance consultant, they switched from a preferred
provider organization to a health maintenance organization that didn't
have coinsurance charges for self-injectable drugs such as Avonex. Now,
they pay nothing for the drug...."
".....many patients who rely on specialty drugs are coping with very
serious, long-term medical conditions. "Consumerism" - encouraging
patients to shop wisely for health care - doesn't really apply when such
patients need drugs for which there are few or no alternatives, says
Stone.
"With people as sick as the patients we're talking about, I don't
think they're going to say, 'Is there a less expensive injectable drug I
can take?' " she says. "It's a whole different dynamic."
Next week: Some states seek to require parity on oral cancer drug coverage.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.